2010
DOI: 10.1016/j.actbio.2009.09.027
|View full text |Cite
|
Sign up to set email alerts
|

In vivo performance of absorbable collagen sponges with rosuvastatin in critical-size cortical bone defects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
69
1
2

Year Published

2010
2010
2020
2020

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 69 publications
(74 citation statements)
references
References 48 publications
(70 reference statements)
2
69
1
2
Order By: Relevance
“…In this study the type I collagen was more effective in combination with alendronate than collagen alone (at the end of 4 months), which was in conformity with the study conducted by Sowmya et al on regenerative potential of type I collagen with xenogenic bone grafts in the treatment of infrabony defects [9]. The resorption process in both the study groups was slowed down but was not arrested completely.…”
Section: Dosage and Administrationsupporting
confidence: 74%
See 2 more Smart Citations
“…In this study the type I collagen was more effective in combination with alendronate than collagen alone (at the end of 4 months), which was in conformity with the study conducted by Sowmya et al on regenerative potential of type I collagen with xenogenic bone grafts in the treatment of infrabony defects [9]. The resorption process in both the study groups was slowed down but was not arrested completely.…”
Section: Dosage and Administrationsupporting
confidence: 74%
“…Moreover collagen when used as a carrier causes slow release of the drug over a prolonged period of time [9]. Healiguide is purely a type I collagen sponge which is obtained from selected animal tissues and has been sterilized using ethylene oxide gas.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Such bone related musculoskeletal problems are highly associated with physical disabilities and morbidities (Monjo et al, 2010b). Being inhibitors of the 3-hydroxy-3-methylglutaryl coenzyme A reductase enzyme, statins were investigated as bone forming molecules.…”
Section: Introductionmentioning
confidence: 99%
“…Here, an in vitro study showed that simvastatin is released gradually over time after an initial burst release from HAF. This release pattern was considered to be similar to that observed in several studies using other biomaterials, including alphatricalcium phosphate (TCP) [34], collagen sponge [35], electrospun fiber material [36], as the drug-delivery system. The bone-promoting effect of simvastatin correlated well with concentration [37]; thus, the initial burst release was thought to be a critical phase [34].…”
Section: Discussionmentioning
confidence: 69%